China boosts combat capability in Tibetan Plateau

Agencies
August 14, 2018

Beijing, Aug 14: The Chinese military has set up oxygen stations and introduced high-pressure oxygen therapy and specially designed portable barracks to its troops stationed in the Qinghai-Tibet Plateau to boost combat capability in the high-altitude ranges where oxygen levels are low, official media here reported today.

Chinese official media had been periodically highlighting the training preparations and the combat readiness of the PLA troops in Tibet in the recent months.

According to the official People's Liberation Army (PLA) website 81.cn, all frontline training troops and border outposts have been equipped with oxygen generators and oxygen cylinders.

Also, the Army Medical University's Xinqiao Hospital in Xigaze, which is close to the Line of Actual Control (LAC) with India, is developing a high-pressure oxygen therapy that could effectively solve altitude stress for troops stationed on the plateau, the PLA Daily said.

It said that oxygen therapy, used to cure brain damage and carbon monoxide poisoning, can be calibrated for high altitude.

The improved therapy has proved effective against altitude stress. Oxygen stations have been built along border roads for soldiers to recover stamina, the state-run Global Times reported today.

"Altitude stress makes troops have breathing difficulties, results in headaches and insomnia," the daily quoted a former military officer who served in Tibet as saying.

Thin air damages combat capability, lowers troops' strength and durability, Song Zhongping, a military expert and TV commentator, told the newspaper.

Applying oxygen therapy helped soldiers to recover in the harsh conditions and enhanced their combat capabilities, he said.

Last month, the PLA Daily reported that the special forces of the Chinese military had conducted drills in Tibet, including ground training for helicopter pilots, to test their skills.

In June, Chinese military units stationed in Tibet carried out a drill, the first post-Dokalam, to test their logistics, armament support capabilities as well as military-civil integration in Tibet.

Earlier, official media had reported about China setting up an unmanned automatic weather observation station in Tibet, close to its border with Arunachal Pradesh, to provide meteorological support for its fighter jets and missile launches.

According to a latest 81.cn report, the PLA is also improving troops' quality of life.

Beginning last year, it has been replacing the old pre-fabricated houses at Tibetan military bases with portable barracks, specifically designed for plateau areas.

The barracks' design and material make them sturdy, moisture-proof and cold-resistant, even keep the room temperature at 15 degrees Celsius even in the worst of snow storms, the report said.

Equipped with cutting-edge camouflage nets, the barracks are difficult to detect and suitable for field operations, the website reported.

Many soldiers and officers suffer frostbite in Tibet, the former military officer said, noting the new facilities provide strong logistical support and ensured the troops' combat capability.

New barracks and other improvements can let troops have enough rest and guarantee their quality of life so that they can work together with better morale, according to Song.

"Logistical support is essential to plateau combat," he said. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 29,2020

If everything goes as Russia’s expectation, it will be world’s first country to approve a coronavirus vaccine for widespread in the second week of August despite safety and efficacy concerns, according to a report. The adenoviral vector-based vaccine developed by Russian military and government researchers is currently in phase 2 trials.

According to a report from CNN, Russian officials are hoping to get approval for the COVID-19 vaccine developed by the Moscow-based Gamaleya Institute on Agust 10 or even before that. The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first.

“It’s a Sputnik moment,” said Kirill Dmitriev, head of Russia’s sovereign wealth fund, which is financing Russian vaccine research, referring to the successful 1957 launch of the world’s first satellite by the Soviet Union, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” he was quoted as saying.

However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report. The vaccine is in the second phase of testing with developers planning to launch the phase 3 trials sometime after August 3.

Earlier, Interfax reported, citing Health Minister Mikhail Murashko, that the vaccine will be widely used in parallel with phase 3 trials. He said the country plans to vaccinate medics who are at high-risk for COVID-19 next month before clinical trials are completed.

Murashko added that individuals at higher risk of getting infected with the coronavirus such as older people or those with health conditions will also be prioritised for the vaccine, although he did not estimate or reveal when that would happen. The minister added 800 people will be recruited for the phase 3 trials.

Meanwhile, health officials were more cautious considering the fact that human testing of the vaccine is incomplete, and the state registration is expected to begin after August 3, reported The Moscow Times.

On Monday, Moderna and Pfizer announced the commencement of the final phase 3 trials of their candidate vaccines against the SARS-CoV-2 virus, which has so far claimed at least 654,477 lives and infected 16,514,500 people worldwide. 

Researchers will recruit up to 30,000 volunteers in separate trials both backed by the US government. India's first indigenous coronavirus vaccine, COVAXIN, is undergoing phase 1 human clinical trials across the country. More than 150 COVID-19 vaccines are being developed all over the world with at least six candidates already in late-stage clinical trials.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 1,2020

Washington, May 1: The United States on Thursday recorded 29,625 new coronavirus cases, and 2,035 deaths in the last 24 hours, according to Johns Hopkins University.

The total number of coronavirus cases has reached 1,069,534 and the death toll stands at 63,001, CNN reported.

The novel coronavirus has infected more than 3.2 million people and killed at least 233,000 globally, according to Johns Hopkins University.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 26,2020

Apr 26: The Chinese city of Wuhan, where the global coronavirus pandemic began, now has no remaining cases in its hospitals, a health official told reporters on Sunday.

"The latest news is that by April 26, the number of new coronavirus patients in Wuhan was at zero, thanks to the joint efforts of Wuhan and medical staff from around the country," National Health Commission spokesman Mi Feng said at a briefing.

The city had reported 46,452 cases, 56% of the national total. It saw 3,869 fatalities, or 84% of China's total.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.